单期乳房提升联合假体隆乳与初次隆乳的结局基准比较:单术者905例连续病例经验
结果显示两组总体并发症率无统计学显著差异,单期联合手术结局与初次隆乳相当;吸烟者更可能因术后并发症(血清肿)再手术,但假体置换率无差异。
要点
- 单期乳房提升联合假体隆乳总体并发症率与初次隆乳无显著差异
- 吸烟者因术后血清肿再手术风险更高,但假体置换率无差异
- 联合手术患者年龄更大、BMI更高、生育次数更多,口服避孕药使用更少
核心结论
- 单术者经验提示单期乳房提升联合假体隆乳的结局与初次假体隆乳相当。
- 吸烟者更可能因术后并发症(血清肿)再手术,但假体置换率无差异。
研究设计与样本
- 回顾性队列研究,单术者连续病例,2009年4月至2017年5月,随访至少6个月。
主要发现
- 两组总体并发症率无统计学显著差异。
- 联合手术组患者显著更可能年龄更大、BMI更高、生育次数更多,且显著更少使用口服避孕药。
- 吸烟者更可能因术后并发症(血清肿)再手术,但假体置换率无差异。
关键数值与推荐
- 证据等级:治疗性,III级。
临床怎么用
- 单期乳房提升联合假体隆乳可作为与初次隆乳结局相当的术式选择。
- 对吸烟患者应充分告知血清肿相关再手术风险。
局限性
- 单术者经验,回顾性设计,证据等级III级,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Augmentation mastopexy may be a one- or two-stage procedure. Because of the opposing force vectors in augmentation and in mastopexy, some surgeons advocate a two-stage procedure. The literature appears divided on which operation has a more favorable complication profile. The purpose of this review was to benchmark the outcomes of single-stage augmentation mastopexy against those of a commonly performed aesthetic breast operation (primary breast augmentation). METHODS: THE AUTHORS: reviewed electronic patient records of all consecutive female patients who underwent single-stage augmentation mastopexy and primary breast augmentation performed by the first author at our clinic between April of 2009 and May of 2017 with at least a 6-month follow-up. Data from single-stage augmentation mastopexy were benchmarked against the outcomes of primary breast augmentations performed by the same surgeon, for the same period, and at the same clinic. RESULTS: ONE HUNDRED FOUR: single-stage augmentation mastopexies and 801 primary breast augmentations were performed during this period, with mean follow-up of 15.4 months and 14.0 months, respectively. Augmentation mastopexy patients were significantly more likely to be older, have a higher body mass index, have more children, and were significantly less likely to use oral contraceptives. There was no statistically significant difference in overall complication rate between the two groups. CONCLUSIONS: THE AUTHORS': experience suggests that single-stage augmentation mastopexy has outcomes comparable to those of primary breast augmentation. Smokers were more likely to undergo reoperation because of postoperative complication (seroma), but the rate of implant exchange was not different. CLINICAL QUESTION/LEVEL OF EVIDENCE: THERAPEUTIC, III.
引用
- Montemurro P, Cheema M, Hedén P, et al. Benchmarking the Outcomes of Single-Stage Augmentation Mastopexy against Primary Breast Augmentation: A Single Surgeon's Experience of 905 Consecutive Cases. Plast Reconstr Surg. 2019. PMID: 31348337. doi:10.1097/PRS.0000000000005849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。